Key result
Aripiprazole administration led to almost full recovery of dystonic symptoms and challenging behaviors after 3 months in a 10-year-old boy with risperidone-induced tardive dystonia.
Why the study?
Risperidone-induced tardive dystonia is documented in adults, but few case reports and clinical anecdotes exist in children.
Does aripiprazole improve risperidone-induced tardive dystonia in a pediatric patient?
Case Report (n=1)
Does aripiprazole improve risperidone-induced tardive dystonia in a pediatric patient?
Aripiprazole may be an effective and suitable substitute for treating risperidone-induced tardive dystonia in children.
Alerts clinicians to tardive dystonia risk with pediatric risperidone; leaves open incidence, monitoring, and management strategies.
Tardive dystonia (TDt) is one of the extrapyramidal syndromes caused primarily by long-term use of dopamine receptor antagonists such as antipsychotics. Although the risperidone-induced TDt cases have been reported in adults, there are few case reports and clinical anecdotes in children. The first step in treatment is the controlled withdrawal of the drug causing the TDt and, if necessary, a transition to a newer “atypical” antipsychotic class. In this article, we present a case of risperidone-induced tardive dystonia and the efficacy of aripiprazole in a 10-years-old boy with moderate mental retardation and conduct disorder referred to us due to restlessness, aggression, self-mutilation, and leg and hip spasms. The child’s dystonic symptoms and challenging behaviors almost fully recovered 3 months of after the aripiprazole administration. Given that the long-term use of antipsychotics in children is increasingly widespread, TDt should be evaluated and monitored periodically. Furthermore, aripiprazole may be a suitable substitute in the TDt treatment in children.
No takes yet. Share an insight, caveat, or question.
Ayla Cicek (2020) conducted a case report in Risperidone-induced tardive dystonia (n=1). Aripiprazole was evaluated on Recovery of dystonic symptoms and challenging behaviors. Aripiprazole administration led to almost full recovery of dystonic symptoms and challenging behaviors after 3 months in a 10-year-old boy with risperidone-induced tardive dystonia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: